LON:CGEO Georgia Capital (CGEO) Share Price, News & Analysis GBX 4,105 +55.00 (+1.36%) As of 08:29 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Georgia Capital Stock (LON:CGEO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Georgia Capital alerts:Sign Up Key Stats Today's Range 4,015▼ 4,12550-Day Range 3,465▼ 4,18552-Week Range 1,778▼ 4,205Volume29,753 shsAverage Volume317,095 shsMarket Capitalization£1.28 billionP/E Ratio0.91Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Georgia Capital PLC (“Georgia Capital” or “the Group” or “GCAP”– LSE: CGEO LN) is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group’s focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a clinics and diagnostics business, (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20% equity stake in the water utility business and a 19.9% equity stake in LSE premium-listed Bank of Georgia Group PLC (“BoG”), a leading universal bank in Georgia. Read More Receive CGEO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Georgia Capital and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGEO Stock News HeadlinesGeorgia Capital sets June AGM and outlines share buyback frameworkMay 11, 2026 | tipranks.comGeorgia Capital tightens share base with latest buyback and cancellationMay 11, 2026 | tipranks.comPeptide Company Lands Exclusive MMA Wellness PartnershipThe Precision Peptide Company (OTCQB: PNGAF) just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White, reaching millions of combat sports and biohacking followers worldwide. With the FDA moving to remove 12 peptides from restricted Category 2 status, PNGAF was already selling products tied to three of those peptides. The company's patent-pending transdermal patch targets the 63.2% of adults with needle phobia - in a market projected to reach $294 billion by 2033.May 20 at 1:00 AM | The Tomorrow Investor (Ad)Georgia Capital Tightens Capital Base With Latest Share BuybacksApril 27, 2026 | tipranks.comGeorgia Capital Cuts Share Count with Latest Buyback TrancheApril 13, 2026 | tipranks.comGeorgia Capital Discloses CFO Share Transfer to Spouse Under UK MARApril 7, 2026 | tipranks.comGeorgia Capital Cuts Share Count with Latest Buyback TrancheApril 7, 2026 | tipranks.comGeorgia Capital Updates Total Voting Rights and Share CapitalApril 1, 2026 | tipranks.comSee More Headlines CGEO Stock Analysis - Frequently Asked Questions How have CGEO shares performed this year? Georgia Capital's stock was trading at GBX 3,100 at the beginning of 2026. Since then, CGEO shares have increased by 32.5% and is now trading at GBX 4,107.50. How were Georgia Capital's earnings last quarter? Georgia Capital PLC (LON:CGEO) released its quarterly earnings results on Tuesday, February, 24th. The company reported $1,560.54 EPS for the quarter. Georgia Capital had a net margin of 99.61% and a trailing twelve-month return on equity of 39.19%. Read the conference call transcript. How do I buy shares of Georgia Capital? Shares of CGEO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Georgia Capital own? Based on aggregate information from My MarketBeat watchlists, some other companies that Georgia Capital investors own include Ecora Resources (ECOR), Alphamin Resources (AFM), Gold Royalty (GROY), Nomad Royalty (NSR), Polo Resources (POL) and Southern Copper (SCCO). Company Calendar Last Earnings2/24/2026Today5/20/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorIndustrials Industry Conglomerates Sub-IndustryN/A Current SymbolLON:CGEO CIKN/A Webwww.georgiacapital.ge Phone77 2031 784 052FaxN/AEmployees19,815Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 4,528.72 Trailing P/E Ratio0.91 Forward P/E Ratio15.73 P/E GrowthN/ANet Income£157.49 million Net Margins99.61% Pretax MarginN/A Return on Equity39.19% Return on Assets3.51% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick Ratio10.24 Sales & Book Value Annual Sales£1.91 billion Price / Sales0.67 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 8,109.81 per share Price / Book0.51Miscellaneous Outstanding Shares31,257,000Free FloatN/AMarket Cap£1.28 billion OptionableNot Optionable Beta0.64 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (LON:CGEO) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipThe Precision Peptide Company (OTCQB: PNGAF) just signed an exclusive partnership with a NYSE-listed MMA media...The Tomorrow Investor | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredElon isn't wrong, he's just earlyRobert Kiyosaki, author of Rich Dad Poor Dad with over 40 million copies sold, says universal basic income is ...Freedom Financial | SponsoredYour book attachedVeteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...Profits Run | SponsoredThis Biotech Just Flipped From Story to ExecutionAvai Bio (OTCQB: AVAI) has moved into production on its new Master Cell Bank, developed alongside Austrianova,...Equiscreen | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Georgia Capital PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Georgia Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
